BLNC
Balance Labs, Inc. [BLNC] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
BLNC Stock Summary
In the News
BLNC Financial details
Company Rating
Sell
Market Cap
5.09M
Income
-685.23K
Revenue
45K
Book val./share
-0.2
Cash/share
0.01
Dividend
-
Dividend %
-
Employees
4
Optionable
No
Shortable
Yes
Earnings
10 May 2024
P/E
-7.43
Forward P/E
-
PEG
2.24
P/S
113.19
P/B
-1.15
P/C
23
P/FCF
-38.25
Quick Ratio
0.08
Current Ratio
0.08
Debt / Equity
-0.56
LT Debt / Equity
-0.11
-
-
EPS (TTM)
-0.03
EPS next Y
-
EPS next Q
-
EPS this Y
24.89%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
18.53%
Revenue last 5Y
106.03%
Revenue Q/Q
-
EPS Q/Q
-28.89%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-211%
ROE
16%
ROC
0.03%
Gross Margin
100%
Oper. Margin
-281%
Profit Margin
-1523%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.235-1.0
52W High
-
52W Low
-
RSI
43
Rel Volume
-
Avg Volume
-
Volume
500
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-2.13%
-
-
-
-
Beta
-0.181
-
-
Volatility
0.01%, 0.01%
Prev Close
0%
Price
0.23
Change
0%
BLNC Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
| Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0 | 0 | 0.05 | 0.03 | 0.01 | |
| Net income per share | -0.03 | -0.04 | 0.01 | -0.05 | -0.06 | |
| Operating cash flow per share | -0.02 | -0.02 | -0.01 | 0 | 0 | |
| Free cash flow per share | -0.02 | -0.02 | -0.01 | 0 | 0 | |
| Cash per share | 0 | 0 | 0 | 0.04 | 0.02 | |
| Book value per share | -0.1 | -0.13 | -0.12 | -0.15 | -0.19 | |
| Tangible book value per share | -0.1 | -0.14 | -0.12 | -0.16 | -0.19 | |
| Share holders equity per share | -0.1 | -0.13 | -0.12 | -0.15 | -0.19 | |
| Interest debt per share | 0.08 | 0.09 | 0.11 | 0.12 | 0.12 | |
| Market cap | 29.19M | 16.22M | 7.15M | 15.61M | 5.09M | |
| Enterprise value | 30.66M | 18.09M | 9.27M | 17.82M | 7.32M | |
| P/E ratio | -53.29 | -17.46 | 29.02 | -15.19 | -3.97 | |
| Price to sales ratio | 4.38K | 4.87K | 7.15 | 24.98 | 20.58 | |
| POCF ratio | -69.45 | -44.38 | -32.81 | -274.28 | 656.96 | |
| PFCF ratio | -68.77 | -44.38 | -32.81 | -235.03 | 656.96 | |
| P/B Ratio | -14.09 | -5.61 | -2.82 | -4.69 | -1.22 | |
| PTB ratio | -14.09 | -5.61 | -2.82 | -4.69 | -1.22 | |
| EV to sales | 4.6K | 5.43K | 9.27 | 28.53 | 29.56 | |
| Enterprise value over EBITDA | -51.15 | -26.64 | 17.89 | 67.21 | -109.57 | |
| EV to operating cash flow | -72.96 | -49.47 | -42.52 | -313.23 | 943.74 | |
| EV to free cash flow | -72.24 | -49.47 | -42.52 | -268.42 | 943.74 | |
| Earnings yield | -0.02 | -0.06 | 0.03 | -0.07 | -0.25 | |
| Free cash flow yield | -0.01 | -0.02 | -0.03 | 0 | 0 | |
| Debt to equity | -0.77 | -0.65 | -0.84 | -0.73 | -0.59 | |
| Debt to assets | 5.09 | 7.89 | 1.67 | 2.41 | 5.73 | |
| Net debt to EBITDA | -2.46 | -2.74 | 4.08 | 8.36 | -33.3 | |
| Current ratio | 0.04 | 0.01 | 0.01 | 0.11 | 0.1 | |
| Interest coverage | -4.64 | -3.34 | 2.98 | 0.92 | -0.1 | |
| Income quality | 0.71 | 0.41 | -0.62 | 0.07 | -0.01 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 91.45 | 168.4 | 0.39 | 0.64 | 1.09 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.01 | 0.01 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0.01 | 0 | 0 | 0.17 | 0 | |
| Capex to revenue | -0.63 | 0 | 0 | -0.02 | 0 | |
| Capex to depreciation | -1.18 | 0 | 0 | -6.71 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 0.23 | 0.36 | 0.17 | 0.4 | 0.51 | |
| ROIC | 1.59 | 0.57 | -1.05 | -0.32 | 0.02 | |
| Return on tangible assets | -1.76 | -3.96 | 0.19 | -1.01 | -2.99 | |
| Graham Net | -0.11 | -0.15 | -0.18 | -0.16 | -0.19 | |
| Working capital | -2.34M | -2.69M | -3.36M | -3.51M | -3.68M | |
| Tangible asset value | -2.12M | -2.94M | -2.59M | -3.39M | -4.16M | |
| Net current asset value | -2.34M | -3.14M | -3.83M | -3.98M | -4.16M | |
| Invested capital | -0.77 | -0.65 | -0.84 | -0.73 | -0.59 | |
| Average receivables | 16.48K | 16.48K | 0 | 99.06K | 121.56K | |
| Average payables | 771.92K | 1.09M | 1.44M | 1.74M | 2M | |
| Average inventory | -15.65K | -15.65K | 0 | -81.35K | -81.35K | |
| Days sales outstanding | 1.8K | 0 | 0 | 115.78 | 66.36 | |
| Days payables outstanding | 0 | 1.79K | 3.76K | 4.67K | 15.61K | |
| Days of inventory on hand | 0 | 0 | 0 | -408.21 | 0 | |
| Receivables turnover | 0.2 | 0 | 0 | 3.15 | 5.5 | |
| Payables turnover | 0 | 0.2 | 0.1 | 0.08 | 0.02 | |
| Inventory turnover | 0 | 0 | 0 | -0.89 | 0 | |
| ROE | 0.26 | 0.32 | -0.1 | 0.31 | 0.31 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
| Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0 | 0 | 0 | 0 | 0 | |
| Net income per share | -0.01 | -0.02 | -0.01 | 0 | 0 | |
| Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Cash per share | 0.01 | 0.02 | 0.02 | 0.02 | 0.01 | |
| Book value per share | -0.18 | -0.19 | -0.2 | -0.2 | -0.2 | |
| Tangible book value per share | -0.18 | -0.19 | -0.2 | -0.2 | -0.2 | |
| Share holders equity per share | -0.18 | -0.19 | -0.2 | -0.2 | -0.2 | |
| Interest debt per share | 0.12 | 0.12 | 0.12 | 0.12 | 0.12 | |
| Market cap | 10.19M | 5.09M | 5.09M | 5.09M | 5.09M | |
| Enterprise value | 12.37M | 7.32M | 7.33M | 7.38M | 7.42M | |
| P/E ratio | -9.72 | -3.92 | -6.54 | -13.16 | -18.53 | |
| Price to sales ratio | 150.92 | 113.19 | 0 | 0 | 0 | |
| POCF ratio | 199.75 | -117.21 | -357.53 | -131.73 | -138.48 | |
| PFCF ratio | 199.75 | -117.21 | -357.53 | -131.73 | -138.48 | |
| P/B Ratio | -2.57 | -1.22 | -1.2 | -1.17 | -1.15 | |
| PTB ratio | -2.57 | -1.22 | -1.2 | -1.17 | -1.15 | |
| EV to sales | 183.3 | 162.6 | 0 | 0 | 0 | |
| Enterprise value over EBITDA | 267.81 | -234.92 | -202.16 | -179.15 | -215.06 | |
| EV to operating cash flow | 242.62 | -168.38 | -514.81 | -190.75 | -201.59 | |
| EV to free cash flow | 242.62 | -168.38 | -514.81 | -190.75 | -201.59 | |
| Earnings yield | -0.03 | -0.06 | -0.04 | -0.02 | -0.01 | |
| Free cash flow yield | 0.01 | -0.01 | 0 | -0.01 | -0.01 | |
| Debt to equity | -0.62 | -0.59 | -0.58 | -0.57 | -0.56 | |
| Debt to assets | 4.39 | 5.73 | 6.56 | 7.29 | 7.61 | |
| Net debt to EBITDA | 47.32 | -71.39 | -61.76 | -55.43 | -67.33 | |
| Current ratio | 0.08 | 0.1 | 0.09 | 0.08 | 0.08 | |
| Interest coverage | 0.74 | -0.35 | -0.55 | -0.72 | -0.6 | |
| Income quality | -0.36 | 0.22 | 0.16 | 0.4 | 0.54 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.37 | 1.44 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.02 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 0.22 | 0.25 | 0.2 | 0.14 | 0.12 | |
| ROIC | -0.05 | 0.02 | 0.04 | 0.03 | 0.02 | |
| Return on tangible assets | -0.48 | -0.76 | -0.52 | -0.29 | -0.21 | |
| Graham Net | -0.2 | -0.19 | -0.2 | -0.2 | -0.2 | |
| Working capital | -3.73M | -3.68M | -3.77M | -3.86M | -3.93M | |
| Tangible asset value | -3.97M | -4.16M | -4.25M | -4.35M | -4.41M | |
| Net current asset value | -4.21M | -4.16M | -4.25M | -4.35M | -4.41M | |
| Invested capital | -0.62 | -0.59 | -0.58 | -0.57 | -0.56 | |
| Average receivables | 124.43K | 44.73K | 22.5K | 0 | 0 | |
| Average payables | 2.05M | 2.1M | 2.15M | 2.19M | 2.24M | |
| Average inventory | -81.48K | -10.98K | 0 | 0 | 0 | |
| Days sales outstanding | 59.28 | 90 | 0 | 0 | 0 | |
| Days payables outstanding | 18.45K | 32.37K | 14.22K | 15.07K | 0 | |
| Days of inventory on hand | -195.86 | 0 | 0 | 0 | 0 | |
| Receivables turnover | 1.52 | 1 | 0 | 0 | 0 | |
| Payables turnover | 0 | 0 | 0.01 | 0.01 | 0 | |
| Inventory turnover | -0.46 | 0 | 0 | 0 | 0 | |
| ROE | 0.07 | 0.08 | 0.05 | 0.02 | 0.02 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
BLNC Frequently Asked Questions
What is Balance Labs, Inc. stock symbol ?
Balance Labs, Inc. is a US stock , located in Miami beach of Fl and trading under the symbol BLNC
What is Balance Labs, Inc. stock quote today ?
Balance Labs, Inc. stock price is $0.23 today.
Is Balance Labs, Inc. stock public?
Yes, Balance Labs, Inc. is a publicly traded company.
Company Profile
- Market Capitalization 5.09M
- Employee 4
- CEO Mr. Michael D. Farkas
- Headquarters Miami Beach,FL,US
- IPO Date 2016-02-16
-
Website
https://www.balancelabs.co 
Balance Labs, Inc. operates as a consulting firm that provides business development and consulting services to startup and development-stage businesses in the United States and internationally. The company offers services that help businesses in various industries to improve and fine tune their business models, sales and marketing plans, and internal operations, as well as make introduction to professional services, such as business plan writing, accounting firms, and legal service providers. It also assists in the development and execution of various services, such as business model development, including marketing research, naming, and branding; financial modeling; Website and mobile app development; employee and board member recruitment; patent/trademark filing assistance; product or service development; product production; marketing material development; product or service placement; celebrity endorsements; and introductions to professional services, such as legal and accounting. The company was incorporated in 2014 and is based in Miami Beach, Florida. Balance Labs, Inc. is a subsidiary of Balance Holdings, LLC.
